CCL5



CCL5

S1SS1P2PP2Y3YY3S4SS4S5SS5D6DD6T7TT7T8TT8P9PP9C10CC10C11CC11F12FF12A13AA13Y14YY14I15II15A16AA16R17RR17P18PP18L19LL19P20PP20R21RR21A22AA22H23HH23I24II24K25KK25E26EE26Y27YY27F28FF28Y29YY29T30TT30S31SS31G32GG32K33KK33C34CC34S35SS35N36NN36P37PP37A38AA38V39VV39V40VV40F41FF41V42VV42T43TT43R44RR44K45KK45N46NN46R47RR47... and 21 more residue(s)...... and 21 more residue(s)

SMILES None
InChIKey None
Sequence SPYSSDTTPCCFAYIARPLPRAHIKEYFYTSGKCSNPAVVFVTRKNRQVCANPEKKWVREYINSLEMS

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections

Structure pdb 7O7F 7F1R

Bioactivities

CCL5

S1SS1P2PP2Y3YY3S4SS4S5SS5D6DD6T7TT7T8TT8P9PP9C10CC10C11CC11F12FF12A13AA13Y14YY14I15II15A16AA16R17RR17P18PP18L19LL19P20PP20R21RR21A22AA22H23HH23I24II24K25KK25E26EE26Y27YY27F28FF28Y29YY29T30TT30S31SS31G32GG32K33KK33C34CC34S35SS35N36NN36P37PP37A38AA38V39VV39V40VV40F41FF41V42VV42T43TT43R44RR44K45KK45N46NN46R47RR47... and 21 more residue(s)...... and 21 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Structure pdb 7O7F 7F1R

Compound is not listed as a drug.